May 2021 Test Bulletin

May 18, 2021

Alverno Laboratories is expanding malaria testing options to include a rapid antigen screen with smear confirmation, providing quicker initial screening results within 24 hours and confirming results with a smear test. In cases of discordant results, samples will be sent to ARUP for PCR detection and speciation. Additionally, Alverno Laboratories has received notification of potential interference affecting estradiol results due to estradiol supplements, with impacted results from October 22, 2019, to April 2021. Clinicians are advised not to use these results to monitor the effectiveness of estradiol supplements and to consider the patient's total clinical presentation when interpreting results, with alternate tests recommended if necessary.